Posted in:

Europe gets early access to Ampligen

Hemispherx and myTomorrows have announced the rollout of an Early Access Program (EAP) in Europe and Turkey to supply rintatolimod (ampligen) to Chronic Fatigue Syndrome (CFS) patients with an unmet medical need.


Written by Russell Logan


Russell Logan worked as a magazine publisher and editor until forced into early retirement through ill health with ME. He has battled with moderate to severe ME for 25 years. He now lives in Noosaville, Australia.

87 posts

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.